Butyrate-CoA ligase
Butyrate-CoA Ligase[edit | edit source]
Butyrate-CoA ligase is an enzyme that plays a crucial role in the metabolism of short-chain fatty acids, particularly butyrate. It catalyzes the conversion of butyrate into butyryl-CoA, a key step in the fatty acid metabolism pathway. This enzyme is important in various biological processes, including energy production and the regulation of gene expression.
Function[edit | edit source]
Butyrate-CoA ligase is involved in the activation of butyrate, a short-chain fatty acid that is produced in the colon by the fermentation of dietary fibers by gut microbiota. The enzyme catalyzes the following reaction:
- Butyrate + CoA + ATP → Butyryl-CoA + AMP + PPi
This reaction is essential for the utilization of butyrate as an energy source by cells, particularly in the liver and colon. Butyryl-CoA can enter the citric acid cycle after further conversion, contributing to ATP production.
Biological Significance[edit | edit source]
Butyrate is known for its beneficial effects on colonic health. It serves as a primary energy source for colonocytes and has anti-inflammatory and anti-carcinogenic properties. The activity of butyrate-CoA ligase is therefore crucial for maintaining the health of the intestinal epithelium.
In addition to its role in energy metabolism, butyrate influences gene expression by acting as a histone deacetylase (HDAC) inhibitor. This epigenetic regulation can affect cell proliferation, differentiation, and apoptosis.
Clinical Relevance[edit | edit source]
Alterations in butyrate metabolism have been associated with various diseases, including inflammatory bowel disease (IBD) and colorectal cancer. Understanding the function and regulation of butyrate-CoA ligase could provide insights into therapeutic strategies for these conditions.
Research and Applications[edit | edit source]
Research into butyrate-CoA ligase includes studies on its structure, regulation, and role in different tissues. Advances in this area could lead to the development of novel treatments targeting metabolic pathways in diseases such as cancer and metabolic disorders.
Also see[edit | edit source]
- Fatty acid metabolism
- Short-chain fatty acids
- Histone deacetylase
- Colorectal cancer
- Inflammatory bowel disease
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD